members only ยป

About us

The SSG was formed in 1979 by physicians and scientists from the Scandinavian countries with a primary interest in tumors of connective tissues.

The goal of the SSG is to advance the care of patients with sarcoma and to increase knowledge of all aspects of the biology of these tumors, including basic and clinical research. The SSG has developed treatment protocols for different sarcoma types and participates in international clinical trials.

At this SSG web-site you can access treatment protocols, find information about previous and future SSG meetings with links to SSG publications.

SSG secretary: Eva-Mari Olofsson
SSG mail address: Eva-Mari.Olofsson@med.lu.se

The Scandinavian Sarcoma Group is a part of Lund University and follows the instructions/regulations for data protection for Lund University.

For more information please, follow this link https://www.lunduniversity.lu.se/about/contact-us/processing-of-personal-data-at-lund-university.

Guidelines

Deadline for all presentations and posters March 31, 2004

Instructions for authors of abstracts for proceedings

The abstracts will be scanned and edited and should for optimal readability be prepared as follows:

Double spaced, typewritten with carbon-band or laserprinted, standing A4, maximum 1 page (250 words).
Use fonts without serif (i.e. Helvetica) or widely spaced letters.
Write the abstract in English.
Line one: Topic (Axial tumors, Secondary malignancies, Biological bone reconstruction, Late relapse sarcomas or Nutrition).
Line two: Title of paper, do not use capital letters only.
Line three: Full names of the authors with the speaker’s name first. No titles.
Line four: Institution or department, city, and country.
Line five: Empty.
Line six and on: The abstract.
Each abstract should be structured under the headings, purpose, patients or subjects, methods, results and discussion.
Figures, tables, and references are accepted.
Figures should be suitable for reproduction in 7.0-cm width.

The abstracts should be sent latest March 31, 2004 to Evy.Nilsson@cancerepid.lu.se